Brain Cancer

BRAIN CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Eponyms in Oncology: Li-Fraumeni Syndrome

This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Li-Fraumeni syndrome.
PTSD in Cancer Patients: What Providers Need to Know

Experts outline risk factors for PTSD and explain how PTSD can affect cancer outcomes.
Genomic Sequencing in Pediatric Cancer: For Every Patient at Every Relapse

More than one-third of tumors sequenced carried a high mutation burden.
How to Prevent a Cyberattack from Derailing Cancer Care

Cyberattacks on health care organizations may not be fully preventable, but there are ways to limit their impact on cancer care.
Changes in Clinical Trial Conduct Prompted by the COVID-19 Pandemic Should Persist

The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.

BRAIN CANCER NEWS

Researchers have identified actionable alterations in nearly 38% of patients with cancer, and almost 18% of patients were assigned to treatments based on their molecular profiling results.

Molecular Profiling Can Guide Treatment After Recurrence in Young Cancer Patients

May 11, 2022

Vials of blood

Blood Biomarkers May Help ID Primary CNS Lymphoma, High-Grade Glioma

April 21, 2022

Image of glioblastoma.

Temozolomide Bests Nivolumab in Glioblastoma With Unmethylated MGMT Promoter

April 19, 2022

Bevacizumab Biosimilar Alymsys Gets FDA Approval

April 15, 2022

Doctor talking to patient.

Assay-Guided Therapy Improves Survival in High-Grade Glioma

April 12, 2022

Next post in Brain Cancer

Image of glioblastoma.

Temozolomide Bests Nivolumab in Glioblastoma With Unmethylated MGMT Promoter